Aytu Biopharma (AYTU) Common Equity (2011 - 2026)
Aytu Biopharma (AYTU) posted Common Equity of $35.27 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 86.0% from $18.97 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Common Equity (2011 - 2026) Analysis & Trends
Since fiscal Q4 2011, Aytu Biopharma has reported Common Equity for 57 quarters.
- Annual Common Equity shows a five-year compound annual growth rate of -23.8% (FY2021 to FY2026).
- In prior fiscal years, Aytu Biopharma's Common Equity was $18.97 million in FY2025 (-31.6%), $27.72 million in FY2024 (-29.6%), $39.36 million in FY2023 (-11.2%) and $44.31 million in FY2022 (-67.8%).
- The fiscal Q4 2026 figure stands as the highest quarterly Common Equity since fiscal Q4 2023.
- On a year-over-year basis, Common Equity increased in three of the last eight quarters, with an average decline of 2.7%.
- The strongest year-over-year quarter for Common Equity in the past five years was fiscal Q4 2026, with growth of 86.0%; the weakest was fiscal Q4 2022, with a decline of 67.8%.
- According to Business Quant data, Common Equity for the three prior fiscal quarters was $35.14 million (Q3 2026), $14.2 million (Q2 2026) and $23.17 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 35.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.27 Mn |
| Mar 31, 2026 | 35.14 Mn |
| Dec 31, 2025 | 14.20 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 18.97 Mn |
| Mar 31, 2025 | 34.90 Mn |
| Dec 31, 2024 | 30.77 Mn |
| Sep 30, 2024 | 29.83 Mn |
| Jun 30, 2024 | 27.72 Mn |
| Mar 31, 2024 | 30.78 Mn |
| Dec 31, 2023 | 32.85 Mn |
| Sep 30, 2023 | 32.17 Mn |
| Jun 30, 2023 | 39.36 Mn |
| Mar 31, 2023 | 40.91 Mn |
| Dec 31, 2022 | 45.82 Mn |
| Sep 30, 2022 | 48.35 Mn |
| Jun 30, 2022 | 44.31 Mn |
| Mar 31, 2022 | 61.14 Mn |
| Dec 31, 2021 | 105.54 Mn |
| Sep 30, 2021 | 111.50 Mn |
API Access
Aytu Biopharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();